Growth Metrics

Genoil (GNOLF) Cost of Revenue (2019 - 2025)

Genoil has reported Cost of Revenue over the past 7 years, most recently at $147005.0 for Q3 2025.

  • Quarterly Cost of Revenue rose 5.62% to $147005.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$25363.0 through Sep 2025, down 119.37% year-over-year, with the annual reading at $339986.0 for FY2020, 91.64% up from the prior year.
  • Cost of Revenue was $147005.0 for Q3 2025 at Genoil, roughly flat from $147506.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $182533.0 in Q2 2024 and troughed at -$459061.0 in Q4 2024.
  • The 5-year median for Cost of Revenue is $116127.0 (2021), against an average of $16361.7.
  • The largest YoY upside for Cost of Revenue was 251.31% in 2021 against a maximum downside of 357.4% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at -$358352.0 in 2021, then rose by 7.77% to -$330514.0 in 2022, then increased by 0.73% to -$328101.0 in 2023, then crashed by 39.91% to -$459061.0 in 2024, then soared by 132.02% to $147005.0 in 2025.
  • Per Business Quant, the three most recent readings for GNOLF's Cost of Revenue are $147005.0 (Q3 2025), $147506.0 (Q1 2025), and -$459061.0 (Q4 2024).